In the last decade, NASA started using Open Innovation approaches to solve some of the world's most complicated problems. Now, the company will need to think about how to solve potential implementation challenges as the company scales up these approaches.
Have the economics of investing in new drug discovery and development become so unattractive that investment in new drugs will come to a halt? GlaxoSmithKline and other bio-pharmaceutical companies are turning to machine learning as a potential solution to make the drug discovery process more efficient, with the hopes of greatly reducing both the time and cost associated with R&D.
Affordable metal 3D printing could democratize manufacturing once and for all
NASA recognizes the power of open innovation to solve tough problems and engage broader audiences, but the mindset shift comes at a price.
Harvard plays an important role in boosting the innovation supply chain
This post delves into the role that supply chain digitization and software innovation will play in the meat production industry, specifically at Tyson Foods.
As drug pricing policies dominate pharmaceutical headlines, the threat of economic nationalism looms even larger over AstraZeneca’s R&D pipeline.
Leveraging science to deliver innovative solutions that meet the challenges of climate change.
Average temperatures around the world have been rising over the past fifty years, and more severe and variable weather patterns have come along for the ride. While climate change has drastic impacts on the environment, we also are seeing significant adverse effects on human health, especially for deadly diseases.